Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - richa+bajpai
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
A Predictive Marker and Treatment to Sensitize Multiple Myeloma Patients to Venetoclax (ABT-199)
Application A marker that predicts Venetoclax (ABT-199) sensitivity that can also be targeted with a drug to help multiple myeloma patients. Key Benefits Marker that predicts if venetoclax will be an effective treatment in multiple myeloma patients. A drug that targets venetoclax resistant multiple myeloma cells to improve treatment in patients. Market...
Published: 7/30/2024
|
Inventor(s):
Malathy (mala) Shanmugam
,
Richa Bajpai
Keywords(s):
Biologic
,
Biomarker
,
Oncology
,
Repurposed Drug
,
Target
Category(s):
TechPub Algolia > Diagnostics
Combination Therapy for Increasing Venetoclax Sensitivity in Multiple Myeloma
Application Marker and co-therapy that inhibits succinate dehydrogenase to increase patient response to venetoclax. Key Benefits Co-therapy increases MM sensitivity to venetoclax treatment. Identifies patients who will respond to venetoclax therapy. Market Summary Multiple Myeloma (MM) is a cancer of plasma cells responsible for making antibody...
Published: 10/28/2024
|
Inventor(s):
Malathy (mala) Shanmugam
,
Richa Bajpai
Keywords(s):
Biologic
,
Biomarker
,
Oncology
,
Rare/Orphan Diseases
,
Repurposed Drug
,
Target
Category(s):
TechPub Algolia > Diagnostics
,
TechPub Algolia > Therapeutics
,
TechPub Algolia > Drug Discovery